Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
€35,82 ↓ -1,80 (-4,78%)
2026-06-05
HİSSE FİYATI
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionKnuff & Co LLC
Latest Disclosed Ownership235,229 shares
Latest Disclosed Value $ 8,644,666
Knuff & Co LLC reports 36.96% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 11, 2026 - Knuff & Co LLC filed a 13F-HR form disclosing ownership of 235,229 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $7,421,475 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 171,750 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 36.96% during the quarter. The current value of the position is $8,425,903 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 235,229 63,479 36.96 8,645 -1.08 2.6049
2026-02-04 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 171,750 -83,274 -32.65 8,739 -38.25 2.5757
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 255,024 127,105 99.36 14,151 60.30 4.0997
2025-08-13 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 127,919 44,053 52.53 8,829 51.61 2.7800
2025-05-13 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 83,866 68,792 456.36 5,824 349.31 1.9541
2025-02-10 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 15,074 7,953 111.68 1,297 53.01 0.3941
2024-11-07 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 7,121 3,954 124.85 848 87.39 0.2588
2024-08-01 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 3,167 3,102 4,772.31 452 5,550.00 0.1467
2024-05-09 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 65 65 8 0.0028
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.